The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Pain wakes me at 3:18 a.m., reminding me that lupus stopped me from working. “Yeah, I know,” I sleep-whisper and stare at the digital clock until box breathing cools me back to sleep. An hour later, 4 ...

Alpine Immune Sciences and Evotec announced the expansion of an agreement to manufacture ALPN-303, an experimental anti-inflammatory therapy that Alpine is developing for systemic lupus erythematosus ...

Lupus News Today is a digital platform intended to provide the lupus community with the most recent news and information, as well as first-hand community perspectives from our patient and caregiver ...

Columnist Marisa Zeppieri shares insight she gained, before she got married, about chronic illness and dating.

Seattle Children's will start a clinical trial testing CAR T-cell therapy in children with lupus this summer after getting FDA clearance.

A recent study of three groups of patients with systemic lupus erythematosus (SLE) has, for the first time, identified a link between iron deficiency and fatigue.

The study will evaluate the safety, pharmacological properties, and efficacy of the CAR NK-cell therapy in people with moderate to severe SLE.

A recent beach adventure prompts columnist Candace Semien to reflect on the value of doing something for the first time.

Read about early research suggesting irinotecan, a topoisomerase I blocker, shows strong potential as a lupus treatment and arguing for studies in patients.

GSK is starting a Phase 3 trial of Benlysta (belimumab) in combination with Rituxan (rituximab) for treating patients with systemic lupus erythematosus (SLE). The ability of the combination to provide ...